Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 100

1.

Chagas, a cardiomyopathy emerging from obscurity.

Westenbrink BD, Kingma JH.

Eur J Heart Fail. 2015 Apr;17(4):355-7. doi: 10.1002/ejhf.261. No abstract available.

2.

Complications after hip arthroplasty and the association with hospital procedure volume.

de Vries LM, Sturkenboom MC, Verhaar JA, Kingma JH, Stricker BH.

Acta Orthop. 2011 Oct;82(5):545-52. doi: 10.3109/17453674.2011.618907. Epub 2011 Sep 6.

3.

Corticosteroids and the risk of atrial fibrillation.

van der Hooft CS, Heeringa J, Brusselle GG, Hofman A, Witteman JC, Kingma JH, Sturkenboom MC, Stricker BH.

Arch Intern Med. 2006 May 8;166(9):1016-20.

PMID:
16682576
4.

Prolonged QTc interval and risk of sudden cardiac death in a population of older adults.

Straus SM, Kors JA, De Bruin ML, van der Hooft CS, Hofman A, Heeringa J, Deckers JW, Kingma JH, Sturkenboom MC, Stricker BH, Witteman JC.

J Am Coll Cardiol. 2006 Jan 17;47(2):362-7.

5.

Non-cardiac QTc-prolonging drugs and the risk of sudden cardiac death.

Straus SM, Sturkenboom MC, Bleumink GS, Dieleman JP, van der Lei J, de Graeff PA, Kingma JH, Stricker BH.

Eur Heart J. 2005 Oct;26(19):2007-12. Epub 2005 May 11.

PMID:
15888497
6.

Mortality in patients with hypertension on angiotensin-I converting enzyme (ACE)-inhibitor treatment is influenced by the ACE insertion/deletion polymorphism.

Bleumink GS, Schut AF, Sturkenboom MC, van Duijn CM, Deckers JW, Hofman A, Kingma JH, Witteman JC, Stricker BH.

Pharmacogenet Genomics. 2005 Feb;15(2):75-81.

PMID:
15861031
7.

Absorption kinetics and pharmacodynamics of two oral dosage forms of flecainide in patients with an episode of paroxysmal atrial fibrillation.

Deneer VH, Lie-A-Huen L, Kingma JH, Proost JH, Gossen SA, Stuurman A, Uytdehaag GM, Dunselman PH, Brouwers JR.

Eur J Clin Pharmacol. 2004 Dec;60(10):693-701. Epub 2004 Nov 16.

PMID:
15619132
8.

Drug-induced atrial fibrillation.

van der Hooft CS, Heeringa J, van Herpen G, Kors JA, Kingma JH, Stricker BH.

J Am Coll Cardiol. 2004 Dec 7;44(11):2117-24. Review.

9.

Rate control is more cost-effective than rhythm control for patients with persistent atrial fibrillation--results from the RAte Control versus Electrical cardioversion (RACE) study.

Hagens VE, Vermeulen KM, TenVergert EM, Van Veldhuisen DJ, Bosker HA, Kamp O, Kingma JH, Tijssen JG, Crijns HJ, Van Gelder IC; RACE study group.

Eur Heart J. 2004 Sep;25(17):1542-9.

PMID:
15342174
10.

Antipsychotics and the risk of sudden cardiac death.

Straus SM, Bleumink GS, Dieleman JP, van der Lei J, 't Jong GW, Kingma JH, Sturkenboom MC, Stricker BH.

Arch Intern Med. 2004 Jun 28;164(12):1293-7. Erratum in: Arch Intern Med. 2004 Sep 27;164(17):1839.

PMID:
15226162
11.

Oral antiarrhythmic drugs in converting recent onset atrial fibrillation.

Deneer VH, Borgh MB, Kingma JH, Lie-A-Huen L, Brouwers JR.

Pharm World Sci. 2004 Apr;26(2):66-78. Review.

PMID:
15085940
12.

Apolipoprotein E epsilon4 allele is associated with left ventricular systolic dysfunction.

Bleumink GS, van Duijn CM, Kingma JH, Witteman JC, Hofman A, Stricker BH.

Am Heart J. 2004 Apr;147(4):685-9.

PMID:
15077085
13.

Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study.

Hagens VE, Ranchor AV, Van Sonderen E, Bosker HA, Kamp O, Tijssen JG, Kingma JH, Crijns HJ, Van Gelder IC; RACE Study Group.

J Am Coll Cardiol. 2004 Jan 21;43(2):241-7.

PMID:
14736444
14.

A randomized study of combining maze surgery for atrial fibrillation with mitral valve surgery.

Jessurun ER, van Hemel NM, Defauw JJ, Brutel De La Rivière A, Stofmeel MA, Kelder JC, Kingma JH, Ernst JM.

J Cardiovasc Surg (Torino). 2003 Feb;44(1):9-18.

PMID:
12627066
15.

Rate or rhythm control for persistent atrial fibrillation.

Hagens VE, van Gelder IC, Tijssen JG, Bosker HA, Kingma JH, Kamp O, Crijns HJ.

Neth Heart J. 2003 Mar;11(3):146-149. No abstract available.

16.

A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation.

Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, Said SA, Darmanata JI, Timmermans AJ, Tijssen JG, Crijns HJ; Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group.

N Engl J Med. 2002 Dec 5;347(23):1834-40.

17.

Buccal transport of flecainide and sotalol: effect of a bile salt and ionization state.

Deneer VH, Drese GB, Roemelé PE, Verhoef JC, Lie-A-Huen L, Kingma JH, Brouwers JR, Junginger HE.

Int J Pharm. 2002 Jul 8;241(1):127-34.

PMID:
12086728
18.

Rate control versus electrical cardioversion for atrial fibrillation: A randomised comparison of two treatment strategies concerning morbidity, mortality, quality of life and cost-benefit - the RACE study design.

van Gelder IC, Hagens VE, Kingma JH, Bosker HA, Kamp O, Kingma T, Veeger NJ, Bouma J, TenVergert EM, Tijssen JG, Crijns HJ.

Neth Heart J. 2002 Mar;10(3):118-124.

19.

[Infectious diseases as a weapon: vigilance is needed].

Kingma JH, van Wijngaarden JK.

Ned Tijdschr Geneeskd. 2001 Dec 8;145(49):2364-5. Review. Dutch.

PMID:
11770262
20.

Morbidity and mortality in patients waiting for coronary artery bypass surgery.

Koomen EM, Hutten BA, Kelder JC, Redekop WK, Tijssen JG, Kingma JH.

Eur J Cardiothorac Surg. 2001 Mar;19(3):260-5.

PMID:
11251263

Supplemental Content

Loading ...
Support Center